As the use of pharmaceuticals can have a substantial impact on a patient's health and well-being, the information on the label must be clear and correct. It is particularly true when it comes to usage directions, expiration dates and component lists. Thus, an audit of pharmaceutical labeling operations is required.
- August 31, 2021 Pharmaceuticals, Regulatory Labeling
- August 30, 2021 Cosmetics Regulatory Services, Regulatory Affairs
Brazil is the largest cosmetic market in the Latin American region. Increasing consumer awareness and a rising disposable income ensure steady market growth. Major international cosmetic brands also have a presence in this attractive market.
Communication effectiveness across the marketing platforms is evaluated primarily based on how well the content engages the audience or, in the case of brands, the consumer. In healthcare, the information available on these platforms is diverse. There are many variations to multiple content types therefore, such boundless volume of content and technical terms may overwhelm the audience with information.
- August 26, 2021 Medical and Scientific Communication, Regulatory Artwork Services
“Colors, like features, follow the changes of the emotions.” - Pablo Picasso
- August 24, 2021 Chemicals, Cosmetics Regulatory Services, Regulatory Affairs
Skincare has been a vital element of human routine for ages and consumers have been trailing behind the beauty of perfect skin and so have the companies. The use of various chemical agents to maintain skin health can sometimes be toxic to the skin.
- August 24, 2021 Consumer Healthcare, Regulatory Affairs
It is crucial for Regulatory bodies to monitor the vast range of consumer products available in their market. With new products entering the market regularly, this task becomes increasingly complex for Regulatory Authorities. However, it is important to detect potentially harmful products to ensure product compliance and consumer safety.
- August 12, 2021 Chemicals, Regulatory Affairs
With the outbreak of the global pandemic, Malaysia continues to fight the war against COVID-19. This period has been overwhelming for both the Malaysian Pharmaceutical industry as well as the consumers. As public and personal hygiene became the first defense against the virus, change in consumer behavior has been observed, especially regarding hygiene-related products in the Malaysian market.
- August 6, 2021 Medical Devices
The Thai Food and Drug Administration (TFDA) has revised its medical device regulations to ensure the safety and effectiveness of the devices marketed in Thailand and to harmonize the regulations with the other ASEAN countries. There have been changes in the medical device classification, registration pathways and process, timelines and fees.
- August 6, 2021 Medical Devices
The US Food and Drug Administration (FDA) defines Clinical Outcome Assessment (COA) as a narration and reflection of how a person feels, functions or survives. The medical device manufacturers may opt to include Clinical Outcome Assessments (COA) in the Regulatory submissions for their device approvals such as PMA and 510(k).
- August 5, 2021 Medical Devices
Many Medical devices and Invitro Diagnostic (IVD) manufacturers gain market authorizations or device approvals in Australia using the conformity assessment certification issued by the EU Notified Bodies.
Below are the various factors affecting or impacting device registration in Australia.